Notice NOT-FD-17-012 from the NIH Guide for Grants and Contracts

Notice NOT-MH-17-044 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-DK-17-503 from the NIH Guide for Grants and Contracts. The NIDDK, in collaboration with the NHLBI and NICHD, invites Cooperative Agreement applications for a limited competition from the Data Coordinating Center (DCC) for The Chronic Kidney Disease in Children (CKiD) consortium. The DCC will work cooperatively with the existing Clinical Coordinating Centers (CCCs) and Central Biochemistry Laboratory (CBL) of the study as a Consortium. Participant evaluations in some domains will be expanded, and follow-up will extend beyond the onset of End Stage Renal Disease (ESRD).

Funding Opportunity RFA-DK-17-502 from the NIH Guide for Grants and Contracts. The NIDDK, in collaboration with the NHLBI and NICHD, invites Cooperative Agreement applications for a limited competition from the two Clinical Coordinating Centers (CCCs) already involved in The Chronic Kidney Disease in Children (CKiD) consortium. The Clinical Centers will continue to evaluate enrolled participants, recruit new participants, and continue to work together cooperatively with the existing Data Coordinating Center (DCC) and Central Biochemistry Laboratory (CBL) of the study as a Consortium. Participant evaluations in some domains will be expanded, and follow-up will extend beyond the onset of End Stage Renal Disease (ESRD).

Funding Opportunity RFA-DK-17-034 from the NIH Guide for Grants and Contracts. The NIDDK invites Cooperative Agreement applications for an open competition for the Central Biochemistry Laboratory (CBL) of The Chronic Kidney Disease in Children (CKiD) consortium. The CBL will work cooperatively with the existing Clinical Coordinating Centers (CCCs) and Data Coordinating Center (DCC) of the study as a Consortium. Participant evaluations in some domains will be expanded, and follow-up will extend beyond the onset of End Stage Renal Disease (ESRD).

Notice NOT-DK-17-017 from the NIH Guide for Grants and Contracts

Notice NOT-RM-17-037 from the NIH Guide for Grants and Contracts

Notice NOT-DK-17-016 from the NIH Guide for Grants and Contracts

May conducts analysis of microarray and high-throughput sequencing data, genome sequence analysis, experimental design and statistical analysis....
From Mount Sinai Health System - Thu, 17 Aug 2017 03:51:36 GMT - View all United States jobs

Bioinformatics and genomics research. The successful candidate will be involved in analysis of genomic data, where....
From Mount Sinai Health System - Wed, 16 Aug 2017 19:46:22 GMT - View all United States jobs

The University of Texas Health Science Center at Houston. The Director will join one of the top research universities in the world, notable for its accomplished...
From The University of Texas Health Science Center at Houston (UTHealth) - Wed, 16 Aug 2017 17:45:44 GMT - View all Texas jobs

Funding Opportunity PA-17-461 from the NIH Guide for Grants and Contracts. The purpose of this initiative is to encourage preclinical and clinical research and secondary data analysis on symptom cluster characterization that has potential to inform treatment and interventions that improve functional outcomes and quality of life in patients with chronic conditions.

Funding Opportunity PA-17-462 from the NIH Guide for Grants and Contracts. The purpose of this initiative is to encourage preclinical and clinical research and secondary data analysis on symptom cluster characterization that has potential to inform treatment and interventions that improve functional outcomes and quality of life in patients with chronic conditions.

Funding Opportunity PA-17-460 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) seeks applications investigating mechanistic and biological aspects of preneoplasia leading to lung, and head and neck (HN) cancers. Despite improved therapies and a deeper molecular understanding of lung and HN cancers, these tumors remain a major health problem in the United States and globally. While molecular markers of early injury to the aerodigestive epithelial field have been found, relatively little is known about the molecular mechanisms that initiate these preneoplasias and drive their progression to invasive cancer. A functional understanding of the key molecular changes involved in the formation and progression of lung and HN preneoplasias will enhance our knowledge of oncogenic progression and accelerate development of effective preventive and therapeutic strategies.

Interdisciplinary team on projects related to bioinformatics, big data science,. Experience with bioinformatics research projects....
From Mount Sinai Health System - Wed, 16 Aug 2017 01:45:06 GMT - View all United States jobs

DOE: Dana-Farber Cancer Institute: Located in Boston and the surrounding communities, Dana-Farber Cancer Institute brings together world renowned clinicians, innovative researchers a... Boston, Massachusetts (US)

The ability to use Bioinformatics software programs and web-based tools to analyze and Interpret NGS data ( Biomedical Genomics WorkBench, BaseSpace, GATK,...
From QIAGEN - Tue, 15 Aug 2017 17:35:57 GMT - View all Atlantic, IA jobs

The ability to use Bioinformatics software programs and web-based tools to analyze and Interpret NGS data ( Biomedical Genomics WorkBench, BaseSpace, GATK,...
From QIAGEN - Tue, 15 Aug 2017 17:35:57 GMT - View all Texas jobs

Notice NOT-OD-17-103 from the NIH Guide for Grants and Contracts

Notice NOT-HD-17-023 from the NIH Guide for Grants and Contracts